Severe Autoimmune Hyperthyroidism in Two Patients with Pulmonary Arterial Hypertension after Treatment with Epoprostenol
نویسندگان
چکیده
Objective: To highlight the increased risk of severe hyperthyroidism leading to decompensation of pulmonary and cardiac hemodynamics post initiation of epoprostenol for treatment of pulmonary arterial hypertension (PAH). Methods: Review of literature shows an increased incidence of autoimmune thyroid disease in patients undergoing treatment of PAH with epoprostenol. We describe two incidences of seropositive thyrotoxicosis associated with acute decompensation of pulmonary and cardiac function. Results: We report two patients with no prior history of thyroid disease who developed severe hyperthyroidism after initiation of epoprostenol. Conclusions: Clinicians should be aware of the potential for development of severe hyperthyroidism leading to rapid decompensation in cardiac and respiratory status after initiation of epoprostenol in patients with PAH. Rapid development of compressive goiter in those treated with prostacyclins is also possible.
منابع مشابه
Aerosolized iloprost therapy could not replace long-term IV epoprostenol (prostacyclin) administration in severe pulmonary hypertension.
OBJECTIVES To switch patients with severe pulmonary hypertension and previous life-threatening catheter-related complications from long-term IV epoprostenol therapy to aerosolized iloprost therapy. DESIGN Open, uncontrolled trial. SETTING Medical ICU of a university hospital. PATIENTS Two patients with primary pulmonary hypertension and one patient with pulmonary hypertension after surgic...
متن کاملLong-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension.
OBJECTIVES To evaluate the effect of long-term oral therapy with sildenafil in patients with pulmonary arterial hypertension receiving long-term IV epoprostenol. DESIGN Open, uncontrolled trial. SETTING University hospital. PATIENTS Two patients with primary pulmonary hypertension and one patient with pulmonary arterial hypertension after surgical closure of an atrial septal defect. All p...
متن کاملElastic recoil of lung and lung reduction surgery.
1 Curnock AL, Dweik RA, Higgins BH, et al. High prevalence of hypothyroidism in patients with primary pulmonary hypertension. Am J Med Sci 1999; 318:289–292 2 Nakchbandi IA, Wirth JA, Inzucchi SE. Pulmonary hypertension caused by Grave’s thyrotoxicosis: normal pulmonary hemodynamics restored by I treatment. Chest 1999; 116: 1483–1485 3 Ferris AM, Morse JH, Barst RJ, et al. Thyroid disease and p...
متن کاملTreatment with epoprostenol of pulmonary arterial hypertension following mitral valve replacement for mitral stenosis.
Pulmonary hypertension frequently complicates mitral stenosis. Increased pulmonary artery pressure results from raised left atrial pressure, pulmonary arteriolar constriction, and obliterative changes in the pulmonary vascular bed, and usually responds to surgical relief of mitral stenosis. However, severe pulmonary hypertension may persist after surgical treatment of mitral stenosis. We descri...
متن کاملBenefits from the correction of vitamin D deficiency in patients with pulmonary hypertension
Background: Vitamin D (Vit D) is linked to various conditions including musculoskeletal, metabolic and cardiopulmonary diseases. However, it is not clear whether correction of vit D deficiency exerts any beneficial effect in patients with pulmonary hypertension. Methods: This study was a prospective uncontrolled longitudinal study. Patients with pulmonary hypertension and vit D d...
متن کامل